SAN JOSE, Calif., Jan. 17 /PRNewswire/ -- Jan Marini Skin Research, Inc. (JMSR; http://www.janmarini.com) today announced that it will voluntarily suspend the sale of its Age Intervention Eyelash Conditioner and Age Intervention Masses of Lashes Mascara products in the U.S.
JMSR cited a patent infringement lawsuit by Allergan Pharmaceutical as one reason for the suspension. "We believe that it makes sense to suspend these products while we strategically review our options," said JMSR President & CEO Jan Marini. "We are assured that the Allergan allegations are unfounded. However, the lawsuit is a major distraction."
JMSR reasserted its confidence in the safety profile of the products, and noted that it has conducted numerous and excellent safety studies. The company maintains its legal right to market both products.
"While these two products have been overwhelmingly popular, JMSR's core skin care products remain the foundation of our business success," said Marini. "Our marketplace is incredibly loyal and supportive. We are preparing to launch new products and are very excited about 2008."
About Jan Marini Skin Research, Inc.
San Jose, CA-based Jan Marini Skin Research, Inc. is a recognized
leader and innovator in skin care, providing state of the art technologies
and breakthroughs in medically-based skin care therapies. JMSR Skin Care
Management System is used and trusted by physicians and skin care
professionals worldwide to ensure optimum results for their patients and
clients. Products range from Glycolic Acid formulas and patented
breakthroughs to the state-of-the-art anti-aging properties of the
remarkable C-ESTA(R) family of products, all aimed at addressing aging
skin, acne, rosacea and other common skin concerns. For more information,
please visit http://www.janmarini.com
Contact: Megan Meece Mark Marinovich
Zing USA Jan Marini Skin Research, Inc.
(212) 633-6301 (408) 362-0130, Ext. 325
|SOURCE Jan Marini Skin Research, Inc.|
Copyright©2008 PR Newswire.
All rights reserved